Molecular imaging firm Blue Earth Diagnostics and GE Healthcare have signed an agreement to manufacture Blue Earth's PET imaging agent Axumin (fluciclovine F-18) in the U.K.
After receiving marketing authorization for Axumin from the European Commission in May, Blue Earth Diagnostics is building a network of manufacturing locations across Europe. The agreement with GE marks the first step toward full commercial availability of Axumin to PET imaging centers in the U.K., according to the firm.
Blue Earth also recently announced manufacturing and distribution agreements in France, Germany, Republic of Ireland, Italy, Portugal, and Spain.
